Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

Stem cell research leaders NYSCF, HSCI join forces
January 2012
SHARING OPTIONS:

NEW YORK—The Harvard Stem Cell Institute (HSCI) and the New York Stem Cell Foundation (NYSCF) recently announced a joint effort to accelerate new treatments for a multitude of indications through the drug discovery process. The U.S. National Institutes of Health estimate that currently, only one of every 10,000 compounds discovered in research is approved for clinical use, and it takes an average of 14 years and $1.2 billion before treatments are available to patients. The collaboration will accelerate work at both organizations' labs in which stem cells are being utilized to recreate diseased cells, which are then used to screen new drugs for effectiveness.   "This latest agreement strengthens already existing ties between NYSCF and HSCI to move promising research more quickly from bench to clinic," said Susan L. Solomon, CEO of NYSCF. 


Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.